Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of particulate matter - Glass like particles.
- Products
-
- Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL
- Company
- Imprimis NJOF, LLC
- Where it was sold
-
U.S Nationwide
Nationwide
- Units affected
- 314 boxes of 6,280 pre-filled syringes
- About this recall
- Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.